MOLINA HEALTHCARE INC (MOH) Fundamental Analysis & Valuation
NYSE:MOH • US60855R1005
Current stock price
141.74 USD
+6.5 (+4.81%)
At close:
141.74 USD
0 (0%)
After Hours:
This MOH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MOH Profitability Analysis
1.1 Basic Checks
- In the past year MOH was profitable.
- In the past year MOH has reported a negative cash flow from operations.
- MOH had positive earnings in each of the past 5 years.
- Of the past 5 years MOH 4 years had a positive operating cash flow.
1.2 Ratios
- MOH's Return On Assets of 3.03% is fine compared to the rest of the industry. MOH outperforms 63.00% of its industry peers.
- The Return On Equity of MOH (11.60%) is better than 76.00% of its industry peers.
- MOH has a Return On Invested Capital of 7.39%. This is in the better half of the industry: MOH outperforms 69.00% of its industry peers.
- MOH had an Average Return On Invested Capital over the past 3 years of 14.32%. This is significantly above the industry average of 8.86%.
- The last Return On Invested Capital (7.39%) for MOH is well below the 3 year average (14.32%), which needs to be investigated, but indicates that MOH had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROIC | 7.39% |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
1.3 Margins
- MOH has a Profit Margin (1.04%) which is comparable to the rest of the industry.
- MOH's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 1.73%, MOH is in line with its industry, outperforming 47.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of MOH has declined.
- MOH's Gross Margin of 13.07% is on the low side compared to the rest of the industry. MOH is outperformed by 67.00% of its industry peers.
- In the last couple of years the Gross Margin of MOH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% |
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
2. MOH Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MOH is creating some value.
- The number of shares outstanding for MOH has been reduced compared to 1 year ago.
- The number of shares outstanding for MOH has been reduced compared to 5 years ago.
- MOH has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.16 indicates that MOH is not in any danger for bankruptcy at the moment.
- MOH has a Altman-Z score of 4.16. This is in the better half of the industry: MOH outperforms 79.00% of its industry peers.
- A Debt/Equity ratio of 0.97 indicates that MOH is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.97, MOH perfoms like the industry average, outperforming 42.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.16 |
ROIC/WACC0.91
WACC8.09%
2.3 Liquidity
- A Current Ratio of 1.69 indicates that MOH should not have too much problems paying its short term obligations.
- The Current ratio of MOH (1.69) is better than 70.00% of its industry peers.
- MOH has a Quick Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
- With a decent Quick ratio value of 1.69, MOH is doing good in the industry, outperforming 72.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 |
3. MOH Growth Analysis
3.1 Past
- The earnings per share for MOH have decreased strongly by -52.98% in the last year.
- The Earnings Per Share has been decreasing by -0.02% on average over the past years.
- Looking at the last year, MOH shows a quite strong growth in Revenue. The Revenue has grown by 11.75% in the last year.
- Measured over the past years, MOH shows a quite strong growth in Revenue. The Revenue has been growing by 18.52% on average per year.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
3.2 Future
- MOH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.69% yearly.
- Based on estimates for the next years, MOH will show a small growth in Revenue. The Revenue will grow by 4.17% on average per year.
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue Next Year-1.25%
Revenue Next 2Y1.97%
Revenue Next 3Y2.94%
Revenue Next 5Y4.17%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. MOH Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 13.31, which indicates a correct valuation of MOH.
- Compared to the rest of the industry, the Price/Earnings ratio of MOH indicates a rather cheap valuation: MOH is cheaper than 85.00% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 25.50. MOH is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 18.23, the valuation of MOH can be described as rather expensive.
- MOH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MOH is cheaper than 66.00% of the companies in the same industry.
- MOH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.67.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.31 | ||
| Fwd PE | 18.23 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -1.38 |
4.3 Compensation for Growth
- MOH's earnings are expected to grow with 13.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.58%
EPS Next 3Y13.62%
5. MOH Dividend Analysis
5.1 Amount
- MOH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MOH Fundamentals: All Metrics, Ratios and Statistics
141.74
+6.5 (+4.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)04-22 2026-04-22/amc
Inst Owners105.33%
Inst Owner Change-7.91%
Ins Owners1.33%
Ins Owner Change10.61%
Market Cap7.30B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts65
Price Target156.67 (10.53%)
Short Float %6.99%
Short Ratio1.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-12.12%
PT rev (3m)-10.16%
EPS NQ rev (1m)-29.26%
EPS NQ rev (3m)-41.87%
EPS NY rev (1m)-44.06%
EPS NY rev (3m)-42.68%
Revenue NQ rev (1m)-1.68%
Revenue NQ rev (3m)-6.19%
Revenue NY rev (1m)-1.92%
Revenue NY rev (3m)-5.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.31 | ||
| Fwd PE | 18.23 | ||
| P/S | 0.16 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.79 | ||
| P/tB | 3.9 | ||
| EV/EBITDA | -1.38 |
EPS(TTM)10.65
EY7.51%
EPS(NY)7.78
Fwd EY5.49%
FCF(TTM)-12.35
FCFYN/A
OCF(TTM)-10.39
OCFYN/A
SpS882.06
BVpS79.01
TBVpS36.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number137.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROCE | 9.57% | ||
| ROIC | 7.39% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% | ||
| FCFM | N/A |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.03 | ||
| Cap/Depr | 51.79% | ||
| Cap/Sales | 0.22% | ||
| Interest Coverage | 4.33 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.16 |
F-Score4
WACC8.09%
ROIC/WACC0.91
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year-1.25%
Revenue Next 2Y1.97%
Revenue Next 3Y2.94%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-29.1%
EBIT Next 3Y6.7%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A
MOLINA HEALTHCARE INC / MOH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 4 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 3 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Overvalued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for MOH stock?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 13.31 and the Price/Book (PB) ratio is 1.79.